SMDPY Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Sumitomo Pharma Co Ltd

Watchlist Manager

Watchlist

Price: 10.525 USD 13.17% Market Closed

Market Cap: $4.2B

	Sumitomo Pharma Co Ltd OTC:SMDPY	JP
	Centaurus Metals Ltd ASX:CTM	AU
B	Barclays PLC OTC:BCLYF	UK
	Dlocal Ltd NASDAQ:DLO	UY
L	Landmark Property Development Co Ltd NSE:LPDC	IN

Profitability Summary

Sumitomo Pharma Co Ltd's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

55%

Strong 3Y Average Gross Margin

60%

Declining Gross Margin

65% > 55%

Healthy Operating Margin

21%

Negative 3Y Average Operating Margin

-23%

Operating Margin is Increasing

-22% > 21%

Healthy Net Margin

24%

Negative 3Y Average Net Margin

-23%

Net Margin is Increasing

-31% > 24%

Exceptional Free Cash Flow Margin

15%

Negative 3Y Average Free Cash Flow Margin

-21%

Free Cash Flow Margin is Increasing

-31% > 15%

Exceptional ROE

39%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-6%

ROIC is Increasing

-13% > 16%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

55%

Strong 3Y Average Gross Margin

60%

Declining Gross Margin

65% > 55%

Healthy Operating Margin

21%

Negative 3Y Average Operating Margin

-23%

Operating Margin is Increasing

-22% > 21%